Stop me if you’ve heard this one. Recently, Akiri, a spin out of Health2047, an integrated innovation enterprise whose founding investor is the American Medical Association, announced the first network-as-a-service (NaaS) platform to the entire healthcare industry. Whoopie! Basically, Akiri is intended to make it easier to transmit data between pharmacies, patients, and physicians using blockchain technology (read: bitcoin) to help transmit information securely through codes. Apparently blockchain technology has many potential implementations (good Deloitte article) past the financial services industry, including the transmission of medical records/data. According to Akiri, the technology has “benefits extending beyond health information exchanges (HIEs), extract, transform, load (ETL) processes, and EMR systems.” Great, hopefully it will solve this issue posed by Dr. Rosenrosen.
The American Medical Association recently announced it was starting the Integrated Health Model Initiative (IHMI). IHMI is a platform for bringing together the health and technology sectors around a common data model and is open to all health care and technology stakeholders. Early collaborators include IBM, Cerner, Intermountain Healthcare, American Heart Association, American Medical Informatics Association, among others. For a pretty cool video on the initiative, look here. Given the economic and societal burden of chronic diseases, IHMI will initially prioritize its resources and efforts in areas such as hypertension, diabetes and asthma. Most large, standards-based, open-collaborations do succeed, right? We hope it does succeed and we don’t end up asking “what would you say… ya do here?”
Profounda, Inc. CEO Todd MacLaughlan recently stopped by the social media site reddit for an AMA (that’s an acronym for “Ask Me Anything,” for the internet noobs in our audience.) Profounda’s drug Impavido, was recently used in Orlando to save a 16 year-old from brain eating amoebas. Redditors asked him, well, anything, from questions about the drug’s mechanism of action and how it’s packaged, to whether or not he’s tried pepper jelly on crackers (spoiler: he hasn’t.) MacLaughlan apparently did well, with many site members lauding him for answering questions like the pepper jelly one, making the appearance feel less like a PR campaign. Pro-tip: redditors will also like you if you make sure to distance yourself from ever-toxic “Pharma bro” Martin Shkreli.